Quellis is a biopharmaceutical company focused on discovering new molecules to treat serious rare diseases. The company aims to improve the lives of patients by developing antibody therapies. It researches, develops and optimizes monoclonal antibodies. The lead Quellis program targets the discovery of a molecule with high performance and the optimization of discovered monoclonal antibodies. They engineer these monoclonal antibodies to include features intended to deliver greater value and improve patients’ lives.
|HQ||Boston, MA, US||Map|
Quellis Biosciences total Funding
Quellis Biosciences latest funding size
Time since last funding
|a year ago|
When was Quellis Biosciences founded?
Quellis Biosciences was founded in 2017.
Who are Quellis Biosciences key executives?
Quellis Biosciences's key executives are Chris Garabedian, Jonathan Violin and Vahe Bedian.
Who are Quellis Biosciences competitors?
Competitors of Quellis Biosciences include BioSpecifics Technologies, Y-mAbs Therapeutics and AiCuris.
Where is Quellis Biosciences headquarters?
Quellis Biosciences headquarters is located at 240 Newbury St 2nd floor, Boston.
Where are Quellis Biosciences offices?
Quellis Biosciences has an office in Boston.
How many offices does Quellis Biosciences have?
Quellis Biosciences has 1 office.
Receive alerts for 300+ data fields across thousands of companies